Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Microchip Technology to Present at the Raymond James 46ᵗʰ Annual Investors Conference
-
MarketWise Declares Dividend on Common Stock
-
MariMed Completes Acquisition of First State Compassion, Strengthening Market Position in Delaware
-
A.I.S. Resources Appoints Marc Enright-Morin Director and Changes Fiscal Year End
-
LeMaitre to Participate at Upcoming Investor Conferences in March
-
Petrus Resources Declares Monthly Dividend for March 2025
-
Top Producing Manager Liz Ryan Returns to Rate in the Northeast, Resumes Decade Long Run
-
KOIL Energy Announces Expansion into Brazil with a New Manufacturing and Service Support Facility
-
Fairfax Announces Quarterly Dividend On Series E, F, G, H, I, J, K and M Preferred Shares and Quarterly Dividend Rate for Series H and J Preferred Shares
-
Plug Power Announces Continued Cash Flow Improvement and Progress on Path to Profitability
-
Brookfield Announces Reset Dividend Rate on Its Series 38 Preference Shares
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Live Oak Acquisition Corp. V Completes $230,000,000 Initial Public Offering
-
reAlpha’s AiChat Unveils Next-Gen AI Agents
-
Guggenheim Investments Announces March 2025 Closed-End Fund Distributions
-
Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum
-
W&T Offshore Announces Fourth Quarter and Full Year 2024 Results Including Year-End 2024 Proved Reserves, Provides Guidance for 2025 and Declares Dividend for First Quarter of 2025
-
FibroGen to Report Fourth Quarter and Full Year 2024 Financial Results
-
VAALCO Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
-
Innovative Food Holdings, Inc. Announces Q4 and Full Fiscal Year 2024 Earnings Call
-
Origin Bancorp, Inc. Provides Update on Board of Directors
-
23andMe Special Committee Rejects Acquisition Proposal From CEO Anne Wojcicki
-
Christine P. Ball Appointed to the Board of Hanmi Financial Corporation
-
ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2024 Financial Results and Participation at Upcoming Conferences
-
James River Announces Fourth Quarter 2024 Results
-
Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
-
Premier American Uranium Engages ICP Securities Inc. for Automated Market Making Services
-
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel® Prefilled Syringe
-
THOR Industries Announces Participation in Upcoming Investor Conferences
-
Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
-
Teva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March
-
Emergent BioSolutions Reports Fourth Quarter and Full Year 2024 Financial Results
-
Exodus Reports Fourth Quarter and Full Year 2024 Results, Provides Preliminary First Quarter 2025 Highlights
-
FEMSA Announces the date for its Annual Shareholders’ Meeting
-
Greenlight Capital Re, Ltd. Schedules Fourth Quarter and Full Year 2024 Financial Results and Conference Call
-
Armada Hoffler Announces Appointment of Jennifer Boykin to the Company’s Board of Directors
-
Microchip Technology to Present at the Raymond James 46th Annual Investors Conference
-
XAI Madison Equity Premium Income Fund Declares its Quarterly Distribution of $0.18 per Share – Fund to Change Distribution Frequency
-
XAI Octagon Floating Rate & Alternative Income Trust Declares its Monthly Common Shares Distribution of $0.077 per Share
-
Employers Holdings, Inc. Appoints Marvin Pestcoe to Board of Directors
-
Acuity Brands to Announce Fiscal 2025 Second-Quarter Results on April 3, 2025
-
Whitestone REIT Reports Fourth Quarter and Full Year 2024 Results
-
Meiwu Technology Company Limited Received Nasdaq Notification Letter Regarding Bid Price Deficiency
-
Lifetime Brands Announces Participation in Upcoming Investor Conferences
-
Earlyworks Co., Ltd. Reports Financial and Operational Performance for the Six Months Ended October 31, 2024
-
Tenaya Therapeutics Announces Proposed Public Offering
-
Gencor Announces Preliminary Unaudited Results
-
ThredUp Announces Fourth Quarter and Full Year 2024 Results
-
Dave Reports Fourth Quarter & Full Year 2024 Financial Results
